News
At our PRovoke EMEA Summit in London last week, we worked with Finn Partners on a panel discussion about“The Power of ...
8d
Vietnam Investment Review on MSNGeorge Clinical Rebrands as Emerald Clinical TrialsNew name reflects company's growth and vision to help bring certainty and transparency to global clinical trials SINGAPORE, April 7, 2025 /PRNewswire/ -- George Clinical, a leading clinical ...
Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies ... As you can imagine, the American pharma company was formed through a ...
Rumours of Trump’s new levy dragged FTSE 100 pharma stocks into the ... when or how much he plans to tariff pharma imports. European pharma companies have called on President of the European ...
Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into ... when or how much he plans to tariff pharma imports. European pharma ...
(Photo by Andy Buchanan – WPA Pool /Getty Images) FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a City broker.
FTSE 100 pharmaceutical giants GSK and Astrazeneca may have avoided ... industry" presents "some perceived risk to near-term guidance" for major pharmaceutical companies. In a positive turn, GSK ...
Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results